Evidence suggests that psychedelic-assisted therapy carries transdiagnostic efficacy in the treatment of mental health conditions characterized by low mood and the use of avoidance coping strategies.
Aims:
While preliminary evidence suggests that psychological flexibility and emotion regulation processes play an important role within psychedelic therapy, this prospective study addressed methodological gaps in the literature and examined the ability of ayahuasca to stimulate acute states of cognitive reappraisal and long-term changes in psychological flexibility and mood. The study also explored whether moderating factors predisposed participants to experience therapeutic changes.
Methods:
Participants (N = 261) were recruited from three Shipibo ayahuasca retreat centers in Central and South America and completed assessments on mood, psychological flexibility, and acute ceremonial factors. Expectancy, demand characteristics, and invalid responding were controlled for with several validity scales.
Results/Outcomes:
Participants reported significant reductions in negative mood after three months, as well as increases in positive mood and psychological flexibility. Acute experiences of reappraisal during the ayahuasca ceremony exerted the strongest moderating effects on increases in positive mood and psychological flexibility. Increases in psychological flexibility statistically mediated the effects of acute psychological factors, including reappraisal, on changes in positive mood.
Conclusions/Interpretation:
These results highlight the role of acute psychological processes, such as reappraisal, and post-acute increases in psychological flexibility as putative mechanisms underlying positive outcomes associated with psychedelics. These results also provide support for the integration of third-wave and mindfulness-based therapy approaches with psychedelic-assisted interventions.
AdamsGDoblesIGomezLH, et al. (2015) Decolonizing psychological science: Introduction to the special thematic section. Journal of Social and Political Psychology3: 213–238.
2.
AdayJSDavisAKMitzkovitzCM, et al. (2021) Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects. ACS Pharmacology & Translational Science4: 424–435.
3.
Agin-LiebesGEkmanEEAndersonBT, et al. (2021) Participant reports of mindfulness, posttraumatic growth, and social connectedness in psilocybin-assisted group therapy: An interpretive phenomenological analysis. Journal of Humanistic Psychology. Epub ahead of print 12June. DOI: 10.1177/00221678211022949.
4.
AldaoANolen-HoeksemaSSchweizerS (2010) Emotion-regulation strategies across psychopathology: A meta-analytic review. Clinical Psychology Review30: 217–237.
5.
BarrettFSJohnsonMWGriffithsRR (2015) Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology29: 1182–1190.
6.
BelserABAgin-LiebesGSwiftTC, et al. (2017) Patient experiences of psilocybin-assisted psychotherapy: An interpretative phenomenological analysis. Journal of Humanistic Psychology57: 354–388.
7.
BondFWHayesSCBaerRA, et al. (2011) Preliminary psychometric properties of the Acceptance and Action Questionnaire-ii: A revised measure of psychological inflexibility and experiential avoidance. Behavior Therapy42: 676–688.
8.
BradleyBDeFifeJAGuarnacciaC, et al. (2011) Emotion dysregulation and negative affect: Association with psychiatric symptoms. Journal of Clinical Psychiatry72: 685–691.
9.
BuhleJTSilversJAWagerTD, et al. (2014) Cognitive reappraisal of emotion: A meta-analysis of human neuroimaging studies. Cerebral Cortex24: 2981–2990.
10.
ByrneBM (2010) Structural Equation Modeling with AMOS: Basic Concepts, Applications, and Programming (2nd edn). New York: Routledge.
11.
Carhart-HarrisRLFristonKJ (2019) REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews71: 316–344.
12.
CherryKMHoevenEVPattersonTS, et al. (2021) Defining and measuring “psychological flexibility”: A narrative scoping review of diverse flexibility and rigidity constructs and perspectives. Clinical Psychology Review84: 101973.
13.
CloseJBHajienECWattsR, et al. (2020) Psychedelics and psychological flexibility —Results of a prospective web-survey using the Acceptance in Action Questionnaire II. Journal of Contextual Behavioral Science16: 37–44.
14.
DavisAKBarrettFSGriffithsRR (2020) Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science15: 39–45.
15.
DavisAKBarrettFSSoS, et al. (2021) Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology35: 437–446.
16.
Dobkin de RiosM (1971) Ayahuasca—the healing vine. International Journal of Social Psychology17: 256–269.
17.
Domínguez-ClavéESolerJPascualJC, et al. (2019) Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits. Psychopharmacology6: 573–580.
18.
ForstmannMYudkinDAProsserAMB, et al. (2020) Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings. Proceedings of the National Academy of Sciences117(5): 2338–2346.
19.
FranquesaASainz-CortAGandyS, et al. (2018) Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach. Psychiatry Research264: 334–339.
20.
FrescoDMMooreMTvan DulmenMH, et al. (2007) Initial psychometric properties of the experiences questionnaire: Validation of a self-report measure of decentering. Behavior Therapy38: 234–246.
21.
FriedrichMJ (2017) Depression is the leading cause of disability around the world. JAMA317: 1517.
22.
GámezWChmielewskiMKotovR, et al. (2014) The brief experiential avoidance questionnaire: Development and initial validation. Psychological Assessment26: 35–45.
23.
GarlandELFredricksonBL (2019) Positive psychological states in the arc from mindfulness to self-transcendence: Extensions of the Mindfulness-to-Meaning Theory and applications to addiction and chronic pain treatment. Current Opinion in Psychology28: 184–191.
24.
GarlandELHanleyAWGoldinPR, et al. (2017) Testing the mindfulness-to-meaning theory: Evidence for mindful positive emotion regulation from a reanalysis of longitudinal data. PLoS ONE12: 1–19.
25.
GeorgeJRMichaelsTISeveliusJ, et al. (2020) The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion. Journal of Psychedelic Studies4: 4–15.
26.
GriffithsRRJohnsonMWCarducciMA, et al. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology30: 1181–1197.
27.
GrossJJJohnOP (2003) Individual differences in two emotion regulation processes: Implications for affect, relationships, and well-being. Journal of Personality and Social Psychology85: 348–362.
28.
HairJFBlackWCBabinBJ, et al. (2010) Multivariate Data Analysis (7th edn). Hoboken, NJ: Prentice Hall.
29.
HartogsohnI (2016) Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology30: 1259–1267.
30.
HayesAFPreacherKJ (2013) Conditional process modeling: Using structural equation modeling to examine contingent causal processes. In: HancockGRMuellerRO (eds) Structural Equation Modeling: A Second Course. Charlotte, NC: IAP Information Age Publishing, pp.219–266.
31.
HayesSCStrosahlKWilsonKG, et al. (2004) Measuring experiential avoidance: A preliminary test of a working model. Psychological Record54: 553–578.
32.
HayesSCVillatteMLevinM, et al (2011) Open, aware, and active: Contextual approaches as an emerging trend in the behavioral and cognitive therapies. Annual Review of Clinical Psychology7: 141–168.
33.
KaasikHSouzaRCZandonadiFS, et al. (2021) Chemical composition of traditional and analog ayahua. Journal of Psychoactive Drugs53: 65–75.
34.
KangaslampiS (2020) Uncovering psychological mechanisms mediating the effects of drugs: Some issues and comments using the example of psychedelic drugs. Psychopharmacology237: 3799–3802.
35.
KashdanTBDisabatoDGoodmanF, et al. (2020) Understanding psychological flexibility: A multimethod exploration of pursuing valued goals despite the presence of distress. Psychological Assessment32: 829–850.
36.
KerrCEJosyulaKLittenbergR (2011) Developing an observing attitude: An analysis of meditation diaries in an MBSR clinical trial. Clinical Psychology & Psychotherapy18: 80–93.
37.
KettnerHRosasFETimmermannC, et al. (2021) Psychedelic communitas: Intersubjective experience during psychedelic group sessions predicts enduring changes in psychological wellbeing and social connectedness. Frontiers in Pharmacology12: 234–254.
KraehenmannRPrellerKHScheideggerM, et al. (2015) Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers. Biological Psychiatry78: 572–581.
40.
KraehenmannRSchmidtAFristonK, et al. (2016) The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. NeuroImage: Clinical11: 53–60.
41.
LakensD (2013) Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Frontiers in Psychology4: 863.
42.
LazarusRSFolkmanS (1984) Stress, Appraisal, and Coping. Berlin: Springer Publishing Company.
43.
LeeRMRobbinsSB (1995) Measuring belongingness: The social connectedness and the social assurance scales. Journal of Counseling Psychology42: 232.
44.
LuomaJBChwylCBathjeGJ, et al. (2020) A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy. Journal of Psychoactive Drugs52: 289–299.
45.
LynamDRGaughanETMillerJT, et al. (2011) Assessing the basic traits associated with psychopathy: Development and validation of the Elemental Psychopathy Assessment. Psychological Assessment23: 108–124.
46.
McRaeKJacobsSERayRD, et al. (2012) Individual differences in reappraisal ability: Links to reappraisal frequency, well-being, and cognitive control. Journal of Research in Personality46: 2–7.
47.
MaerckerAHornAB (2012) A socio-interpersonal perspective on PTSD: The case for environments and interpersonal processes. Clinical Psychology & Psychotherapy20: 465–481.
48.
MaloolyAMGenetJJSiemerM (2013) Individual differences in reappraisal effectiveness: The role of affective flexibility. Emotion13: 302–313.
49.
MertensLJWallMBRosemanL, et al. (2020) Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. Journal of Psychopharmacology34: 167–180.
50.
MichaelsTIPurdonJCollinsA, et al. (2018) Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry18: 1–14.
51.
MorrisLMansellW (2018) A systematic review of the relationship between rigidity/flexibility and transdiagnostic cognitive and behavioral processes that maintain psychopathology. Journal of Experimental Psychology: General9: 2043808718779431.
52.
Murphy-BeinerASoarK (2020) Ayahuasca’s ‘afterglow’: Improved mindfulness and cognitive flexibility in ayahuasca drinkers. Psychopharmacology237: 1161–1169.
53.
MuthukumaraswamySForsythALumleyT (2021) Blinding and expectancy confounds in psychedelic randomised controlled trials. Expert Review of Clinical Pharmacology14: 1133–1152.
54.
NourMMEvansLNuttD, et al. (2016) Ego-dissolution and psychedelics: Validation of the ego-dissolution inventory (EDI). Frontiers in Human Neuroscience10: 1–13.
55.
ÖstLG (2008) Efficacy of the third wave of behavioral therapies: A systematic review and meta-analysis. Behaviour Research and Therapy46: 296–321.
56.
Palhano-FontesFBarretoDOniasH, et al. (2019) Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine49: 655–663.
57.
RochefortCBaldwinASChmielewskiM (2018) Experiential avoidance: An examination of the construct validity of the AAQ-II and MEAQ. Behavior Therapy49: 435–449.
58.
RosemanLHaijenEIdialu-IkatoK, et al. (2019) Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. Journal of Psychopharmacology33: 1076–1087.
59.
RosemanLNuttDJCarhart-HarrisRL (2018) Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology17: 974.
60.
RossSBossisAGussJ, et al. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology30: 1165–1180.
61.
SampedroFde la Fuente RevengaMValleM, et al. (2017) Assessing the psychedelic “after-glow” in ayahuasca users: Post-acute neurometabolic and functional connectivity changes are associated with enhanced mindfulness capacities. International Journal of Neuropsychopharmacology20: 698–711.
62.
SchmeichelBJVolokhovRNDemareeHA (2008) Working memory capacity and the self-regulation of emotional expression and experience. Journal of Personality and Social Psychology95: 1526.
63.
SchultesREFarnsworthNR (1980) Ethnomedical, botanical and phytochemical aspects of natural hallucinogens. Botanical Museum Leaflets28: 123–214.
64.
SheppesGScheibeSSuriG, et al. (2014) Emotion regulation choice: A conceptual framework and supporting evidence. Journal of Experimental Psychology: General143: 163–181.
65.
SimonGE (2003) Social and economic burden of mood disorders. Biological Psychiatry54: 208–221.
66.
SloshowerJGussJKrauseR, et al. (2020) Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame. Journal of Contextual Behavioral Science1: 12–19.
67.
SolerJElicesMDominguez-ClavéE, et al. (2018) Four weekly ayahuasca sessions lead to increases in “acceptance” capacities: A comparison study with a standard 8-week mindfulness training program. Frontiers in Pharmacology9: 224.
68.
SolerJElicesMFranquesaA, et al. (2016) Exploring the therapeutic potential of ayahuasca: Acute intake increases mindfulness-related capacities. Psychopharmacology233: 823–829.
69.
SwiftTCBelserABAgin-LiebesG, et al. (2017) Cancer at the dinner table: Experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. Journal of Humanistic Psychology57: 488–519.
70.
TeasdaleJDMooreRGHayhurstH, et al. (2002) Metacognitive awareness and prevention of relapse in depression: Empirical evidence. Journal of Consulting and Clinical Psychology70: 275–287.
71.
ThiessenMSWalshZBirdBM, et al. (2018) Psychedelic use and intimate partner violence: The role of emotion regulation. Journal of Psychopharmacology32: 749–755.
72.
TryonWW (2018) Mediators and mechanisms. Clinical Psychological Science6: 619–628.
73.
TyndallIWaldeckDRivaP, et al. (2018) Psychological flexibility and ostracism: Experiential avoidance rather than cognitive fusion moderates distress from perceived ostracism over time. Journal of Contextual Behavioral Science7: 72–80.
74.
UthaugMVMasonNLToennesSW, et al. (2021) A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats. Psychopharmacology238: 1899–1910.
75.
VujanovicAAMeyerTDHeadsAM, et al. (2021) Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches. American Journal of Drug and Alcohol Abuse43: 402–415.
76.
WatsonDClarkLATellegenA (1988) Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology54: 1063–1068.
77.
WattsRLuomaJB (2020) The use of the psychological flexibility model to support psychedelic assisted therapy. Journal of Contextual Behavioral Science1: 92–102.
78.
WattsRDayCKrzanowskiJ, et al. (2017) Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology557: 520–564.
79.
WebbTLMilesESheeranP (2012) Dealing with feeling: A meta-analysis of the effectiveness of strategies derived from the process model of emotion regulation. Psychological Bulletin138: 775–808.
80.
WeissBMillerJDCarterNT, et al. (2020) Development of Ayahuasca Experience Inventory. Available at: https://osf.io/9ybmt/
81.
WeissBMillerJDCarterNT, et al. (2021) Examining changes in personality following shamanic ceremonial use of ayahuasca. Scientific Reports11: 1–15.
82.
WolffMEvensRMertensLJ, et al. (2020) Learning to let go: Cognitive-behavioral model of how psychedelic therapy promotes acceptance. Frontiers in Psychiatry11: 1–13.
83.
WolgastM (2014) What does the acceptance and action questionnaire (AAQ-II) really measure?Behavior Therapy45: 831–839.
84.
ZeifmanRJWagnerACWattsR, et al. (2020) Post-psychedelic reductions in experiential avoidance are associated with decreases in depression severity and suicidal ideation. Frontiers in Psychiatry11: 1–13.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
